Mazagon Dock To Add Orders Worth Rs 2,000 Crore In Q3, Says MD
Mazagon Dock Shipbuilders Ltd. expects to add orders worth Rs 2,000 crore in the December quarter, according to Sanjeev Singhal, chairman and managing director of the company.
In October, the company received a small contract of one cadet training ship with Indian coast guard, which works out to around Rs 310 crore, Singhal told BQ Prime's Sajeet Manghat.
By the end of this month, the warship and submarine manufacturer also expects to finalise another project for offshore petrol vessels, which is expected to be around Rs 1,400 crore, Singhal said.
He also expects a positive development on one small value export order to form up in the next two months. "This would be providing us a foothold in the export market segment, which we have been trying for quite some time but have not been able to succeed," said Singhal.
As of September 2023, the company's order book stood at Rs 37,500 crore, said Singhal.
The company's net profit jumped 55.6% year-on-year to Rs 333 crore during the second quarter. Its revenue rose 7.4% to Rs 1,828 crore.
Mazagon Dock Shipbuilders Q2 FY24 Highlights (Consolidated, YoY)
Revenue up 7.4% at Rs 1,828 crore vs Rs 1,702 crore.
Ebitda up 51.33% at Rs 176 crore vs Rs 117 crore.
Margin up 279 basis points at 9.64% vs 6.84%.
Reported profit up 55.6% to Rs 333 crore vs Rs 214 crore.
In the reporting quarter, profitability was driven by a refund of liquidated damages with respect to one of the Scorpion submarines, according to Singhal.
"We are expecting a similar kind of refund which may materialise this quarter or next quarter, which will have a positive impact on the profitability," he said. For the previous two boats, the amount was in the range of Rs 160-170 crore each.
Watch the full conversation here:
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.